Callisia Nathelee Clarke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Callisia Nathelee Clarke has a total of 330 co-authors. Here are the top co-authors by number of shared publications:
- Harveshp Mogal
Department of Surgery, University of Washington Medical Center, Seattle, USA
11 shared publications Konstantinos Votanopoulos
Department of Surgery Wake Forest University Winston‐Salem North Carolina USA
7 shared publicationsCecilia G. Ethun
Division of Surgical Oncology, Winship Cancer Institute Emory University Atlanta Georgia USA
6 shared publications- Daniel E. Abbott
University of Wisconsin Carbone Cancer Center 3 , Madison, Wisconsin
6 shared publications George Poultsides
Department of Surgery Stanford University Medical Center Palo Alto California USA
6 shared publications- Kenneth Cardona
Department of Surgery Emory University School of Medicine Atlanta Georgia USA
6 shared publications
Latest Publications
- Open Access
- 7 August 2026
- Published by Springer Nature in Global Surgical Education - Journal of the Association for Surgical Education
- Vol. 5 (1) , 167
Correction: Strategies to retain and advance diverse surgical trainees: a narrative review
- 7 August 2026
- Published by Springer Nature in Global Surgical Education - Journal of the Association for Surgical Education
- Vol. 5 (1) , 167
Open AccessCorrection: Strategies to retain and advance diverse surgical trainees: a narrative review
- 13 July 2026
- Published by Springer Nature in Global Surgical Education - Journal of the Association for Surgical Education
- Vol. 5 (1) , 152
Strategies to retain and advance diverse surgical trainees: a narrative review
- 13 July 2026
- Published by Springer Nature in Global Surgical Education - Journal of the Association for Surgical Education
- Vol. 5 (1) , 152
Strategies to retain and advance diverse surgical trainees: a narrative review
- 10 July 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 326, 197-201
Association for Academic Surgery Presidential Address – Hidden Figures: They Are all Around Us
- 10 July 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 326, 197-201
Association for Academic Surgery Presidential Address – Hidden Figures: They Are all Around Us
- 7 May 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 322, 513-517
Association for Academic Surgery Founder's Lecture - Addressing the Surgical Workforce Crisis: Retention Strategies for a Thriving Future
- 7 May 2026
- Published by Elsevier in Journal of Surgical Research
- Vol. 322, 513-517
Association for Academic Surgery Founder's Lecture - Addressing the Surgical Workforce Crisis: Retention Strategies for a Thriving Future
- Top Cited Papers
- 1 January 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 22 (1) , 19-35
Symptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual . ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines . Clinical Practice Guidelines and other guidance (“Guidance”) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by clinicians and should be used in conjunction with independent professional judgment. Guidance may not be applicable to all patients, interventions, diseases or stages of diseases. Guidance is based on review and analysis of relevant literature and is not intended as a statement of the standard of care. ASCO does not endorse third-party drugs, devices, services, or therapies and assumes no responsibility for any harm arising from or related to the use of this information. See complete disclaimer in Appendix 1 and 2 (online only) for more. PURPOSE: To develop a clinical practice guideline and recommendations for symptom management of patients with well-differentiated grade 1 to grade 3 metastatic gastroenteropancreatic neuroendocrine tumors. METHODS: ASCO convened an Expert Panel to develop a clinical practice guideline by reviewing the literature for relevant guidelines, systematic reviews, randomized controlled trials (RCTs), and observational studies to develop recommendations for clinical practice. RESULTS: The literature review identified eight guidelines, 19 systematic reviews, and three RCTs that informed the development of guideline recommendations. RECOMMENDATIONS: Recommendations are included for carcinoid syndrome, carcinoid heart disease and carcinoid crisis, and functional pancreatic neuroendocrine tumor syndromes. Recommendations are provided for surgical management, liver-directed therapy, and systemic therapy options, as well as palliative care. Limited guidance is provided for sequencing of interventions. Additional information is available at www.asco.org/gastrointestinal-cancer-guidelines .
- 1 January 2026
- Published by American Society of Clinical Oncology (ASCO) in JCO Oncology Practice
- Vol. 22 (1) , 19-35
Top Cited PapersSymptom Management for Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors: ASCO Guideline
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO Guidelines Methodology Manual . ASCO Guidelines follow the ASCO Conflict of Interest Policy for Clinical Practice Guidelines . Clinical Practice Guidelines and other guidance (“Guidance”) provided by ASCO is not a comprehensive or definitive guide to treatment options. It is intended for voluntary use by clinicians and should be used in conjunction with independent professional judgment. Guidance may not be applicable to all patients, interventions, diseases or stages of diseases. Guidance is based on review and analysis of relevant literature and is not intended as a statement of the standard of care. ASCO does not endorse third-party drugs, devices, services, or therapies and assumes no responsibility for any harm arising from or related to the use of this information. See complete disclaimer in Appendix 1 and 2 (online only) for more. PURPOSE: To develop a clinical practice guideline and recommendations for symptom management of patients with well-differentiated grade 1 to grade 3 metastatic gastroenteropancreatic neuroendocrine tumors. METHODS: ASCO convened an Expert Panel to develop a clinical practice guideline by reviewing the literature for relevant guidelines, systematic reviews, randomized controlled trials (RCTs), and observational studies to develop recommendations for clinical practice. RESULTS: The literature review identified eight guidelines, 19 systematic reviews, and three RCTs that informed the development of guideline recommendations. RECOMMENDATIONS: Recommendations are included for carcinoid syndrome, carcinoid heart disease and carcinoid crisis, and functional pancreatic neuroendocrine tumor syndromes. Recommendations are provided for surgical management, liver-directed therapy, and systemic therapy options, as well as palliative care. Limited guidance is provided for sequencing of interventions. Additional information is available at www.asco.org/gastrointestinal-cancer-guidelines .
- 26 June 2025
- Published by Springer Nature
- p. 179-188
Non-melanomatous Skin Cancers: Squamous Cell Carcinoma and Basal Cell Carcinoma
- 26 June 2025
- Published by Springer Nature
- p. 179-188
Non-melanomatous Skin Cancers: Squamous Cell Carcinoma and Basal Cell Carcinoma
- 31 March 2025
- Published by Springer Nature
- p. 275-293
Pancreatic Ductal Adenocarcinoma
- Open Access
- 23 February 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (5) , 3635
ASO Visual Abstract: Impact of Regional Metastasis on Survival for Patients with Non-functional Pancreatic Neuroendocrine Tumors: A Systematic Review
- 23 February 2025
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 32 (5) , 3635
Open AccessASO Visual Abstract: Impact of Regional Metastasis on Survival for Patients with Non-functional Pancreatic Neuroendocrine Tumors: A Systematic Review
- 6 August 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (3) , 378-381
The End of Race-Conscious Admissions
The end of race-conscious admissions poses a significant challenge to the recruitment of underrepresented in medicine surgical trainees and surgeons in the United States. These developing limitations underscore the importance of retention within the academic surgical pathway as we seek to diversify the physician workforce in order to best serve our patients.
- 6 August 2024
- Published by Wolters Kluwer Health in Annals of Surgery
- Vol. 281 (3) , 378-381
The End of Race-Conscious Admissions
The end of race-conscious admissions poses a significant challenge to the recruitment of underrepresented in medicine surgical trainees and surgeons in the United States. These developing limitations underscore the importance of retention within the academic surgical pathway as we seek to diversify the physician workforce in order to best serve our patients.